Market Research Logo

Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review

Flamel Technologies S.A. (FLML) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Flamel Technologies S.A. (Flamel) is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, CNS (narcolepsy), pain, respiratory diseases and diabetes. The company markets unapproved marketed drugs, Bloxiverz (neostigmine methylsulfate injection), Karbinal ER (Allergy), AchipHex Sprinkle (gastroesophageal disease) and Vazculep (phenylephrine hydrochloride injection). The company has business models such as Unapproved Marketed Drugs (UMD); branded pediatric business and branded business.

Flamel Technologies S.A. Key Recent Developments

Aug 08,2016 Flamel Technologies Reports Second Quarter 2016 Results
May 09,2016 Flamel Technologies Reports First Quarter 2016 Results
Mar 10,2016 Flamel Technologies Reports Fourth Quarter and Full Year 2015 Results
Jan 08,2016 Flamel Technologies Provides Update on Corporate Progress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Flamel Technologies S.A. - Key Facts
Flamel Technologies S.A. - Key Employees
Flamel Technologies S.A. - Key Employee Biographies
Flamel Technologies S.A. - Major Products and Services
Flamel Technologies S.A. - Pharmaceutical Pipeline Products Data
Flamel Technologies S.A., Pipeline Products by Therapy Area
Flamel Technologies S.A., Pipeline Products by Development Phase
Flamel Technologies S.A. - History
Flamel Technologies S.A. - Company Statement
Flamel Technologies S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Flamel Technologies S.A. - Business Description
Flamel Technologies S.A. - Corporate Strategy
Flamel Technologies S.A. - SWOT Analysis
SWOT Analysis - Overview
Flamel Technologies S.A. - Strengths
Flamel Technologies S.A. - Weaknesses
Flamel Technologies S.A. - Opportunities
Flamel Technologies S.A. - Threats
Flamel Technologies S.A. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Flamel Technologies S.A., Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 08, 2016: Flamel Technologies Reports Second Quarter 2016 Results
May 09, 2016: Flamel Technologies Reports First Quarter 2016 Results
Mar 10, 2016: Flamel Technologies Reports Fourth Quarter and Full Year 2015 Results
Jan 08, 2016: Flamel Technologies Provides Update on Corporate Progress
Nov 23, 2015: Flamel Technologies Appoints Michael Kanan Chief Financial Officer
Nov 12, 2015: Flamel Technologies Reports Third Quarter 2015 Results
Jul 30, 2015: Flamel Technologies Announces Second Quarter Results of Fiscal Year 2015
Jun 26, 2015: Flamel Technologies Appoints SVP of Quality and Regulatory Affairs and VP of Business and Corporate Development
May 15, 2015: Flamel Technologies Announces First Quarter Results of Fiscal Year 2015
Apr 07, 2015: Flamel Technologies Announces Departure of Senior Vice President of Business and Corporate Development
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Flamel Technologies S.A., Key Facts
Flamel Technologies S.A., Key Employees
Flamel Technologies S.A., Key Employee Biographies
Flamel Technologies S.A., Major Products and Services
Flamel Technologies S.A., Number of Pipeline Products by Therapy Area
Flamel Technologies S.A., Number of Pipeline Products by Development Stage
Flamel Technologies S.A., Pipeline Products By Therapy Area and Development Phase
Flamel Technologies S.A., History
Flamel Technologies S.A., Subsidiaries
Flamel Technologies S.A., Key Competitors
Flamel Technologies S.A., Ratios based on current share price
Flamel Technologies S.A., Annual Ratios
Flamel Technologies S.A., Interim Ratios
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Flamel Technologies S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Flamel Technologies S.A., Pipeline Products by Therapy Area
Flamel Technologies S.A., Pipeline Products by Development Phase
Flamel Technologies S.A., Performance Chart (2011 - 2015)
Flamel Technologies S.A., Ratio Charts
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Flamel Technologies S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report